NO950897L - Inhibisjon av retro virusinfeksjon - Google Patents

Inhibisjon av retro virusinfeksjon

Info

Publication number
NO950897L
NO950897L NO950897A NO950897A NO950897L NO 950897 L NO950897 L NO 950897L NO 950897 A NO950897 A NO 950897A NO 950897 A NO950897 A NO 950897A NO 950897 L NO950897 L NO 950897L
Authority
NO
Norway
Prior art keywords
inhibition
retroviral infection
slpi
prevention
methods
Prior art date
Application number
NO950897A
Other languages
English (en)
Other versions
NO315546B1 (no
NO950897D0 (no
Inventor
Stephen Eisenberg
Robert C Thompson
Sharon M Wahl
Original Assignee
Amgen Boulder Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Boulder Inc filed Critical Amgen Boulder Inc
Publication of NO950897D0 publication Critical patent/NO950897D0/no
Publication of NO950897L publication Critical patent/NO950897L/no
Publication of NO315546B1 publication Critical patent/NO315546B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
NO19950897A 1992-09-09 1995-03-08 Inhibisjon av retro virusinfeksjon NO315546B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94336992A 1992-09-09 1992-09-09
PCT/US1993/008486 WO1994006454A2 (en) 1992-09-09 1993-09-09 Inhibitiion of retrovirus infection

Publications (3)

Publication Number Publication Date
NO950897D0 NO950897D0 (no) 1995-03-08
NO950897L true NO950897L (no) 1995-03-08
NO315546B1 NO315546B1 (no) 2003-09-22

Family

ID=25479533

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19950897A NO315546B1 (no) 1992-09-09 1995-03-08 Inhibisjon av retro virusinfeksjon

Country Status (23)

Country Link
EP (1) EP0666755B1 (no)
JP (2) JP3517238B2 (no)
KR (1) KR100273620B1 (no)
AT (1) ATE238062T1 (no)
AU (1) AU681350B2 (no)
CA (1) CA2141951C (no)
CZ (1) CZ286953B6 (no)
DE (1) DE69332904T2 (no)
DK (1) DK0666755T3 (no)
ES (1) ES2197153T3 (no)
FI (1) FI951078L (no)
HU (1) HU218892B (no)
NO (1) NO315546B1 (no)
NZ (1) NZ256246A (no)
OA (1) OA10133A (no)
PL (1) PL307864A1 (no)
PT (1) PT666755E (no)
RO (1) RO116164B1 (no)
RU (1) RU2126266C1 (no)
SG (1) SG48115A1 (no)
SK (1) SK281127B6 (no)
UA (1) UA41338C2 (no)
WO (1) WO1994006454A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT75660A (en) * 1994-03-23 1997-05-28 Tokyo Tanabe Co Novel remedy for respiratory-tract viral disease
WO1997003694A1 (en) * 1995-07-24 1997-02-06 Tokyo Tanabe Company Limited Remedy for viral diseases
DK0861085T3 (da) 1995-11-13 2005-11-21 Vitaleech Bioscience N V Antivirale isolater opnået fra igler
US7276333B1 (en) 1999-05-13 2007-10-02 Japan Science And Technology Agency Viral infection inhibitor targeting integrase N-terminal domain
DE10101792B4 (de) * 2001-01-17 2004-03-18 Vivotec Biomedical Technologies Gmbh Verfahren zum Nachweis von Pankreaskarzinom oder chronischer Pankreatitis und Verwendung von Antikörpern
WO2005046732A2 (en) 2003-11-04 2005-05-26 THE UNITED SATES OF AMERICA as represented by THE SECRETARY OF HEALTH AND HUMAN SERVICES, NIH Methods and compositions for the inhibition of hiv-1 replication

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760130A (en) * 1984-12-06 1988-07-26 Synergen Biologicals, Inc. Serine protease inhibitors and methods for isolation of same
CA1340877C (en) * 1987-12-28 2000-01-18 Takashi Sugiyama Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
JP2804979B2 (ja) * 1988-11-28 1998-09-30 日本ケミカルリサーチ株式会社 エイズ治療および阻害剤
CA2007083A1 (en) * 1989-01-09 1990-07-09 Nobuhiko Katunuma Pharmaceutical use of trypstatin
ATE148992T1 (de) * 1989-08-16 1997-03-15 Chiron Corp Zusammensetzungen zur hemmung der bildung von proteinhormon und deren verwendungen
CA2071972A1 (fr) * 1989-12-18 1991-06-19 Bruno Guy Composition pharmaceutique destinee au traitement ou a la prevention des infections retrovirales
GR1001044B (el) * 1991-06-03 1993-04-28 Logothetou Rella Eleni Μηχανισμός διή?ησης νεοπλασματικών κυττάρων και η χρήση του αναστολέα της Ca2+ -εξαρτώμενης ουδέτερης πρωτεάσης για την παρασκευή φαρμακευτικών αντικαρκινικών συν?έσεων.

Also Published As

Publication number Publication date
CA2141951C (en) 2007-04-24
DK0666755T3 (da) 2003-08-04
SG48115A1 (en) 1998-04-17
RO116164B1 (ro) 2000-11-30
SK281127B6 (sk) 2000-12-11
ATE238062T1 (de) 2003-05-15
NO315546B1 (no) 2003-09-22
HUT75126A (en) 1997-04-28
AU4853093A (en) 1994-04-12
ES2197153T3 (es) 2004-01-01
RU95109909A (ru) 1997-03-27
CA2141951A1 (en) 1994-03-31
HU9500682D0 (en) 1995-04-28
NZ256246A (en) 1997-08-22
FI951078A0 (fi) 1995-03-08
DE69332904T2 (de) 2003-11-06
EP0666755A1 (en) 1995-08-16
NO950897D0 (no) 1995-03-08
HU218892B (hu) 2000-12-28
SK29795A3 (en) 1997-02-05
JPH08505042A (ja) 1996-06-04
CZ55995A3 (en) 1996-01-17
CZ286953B6 (en) 2000-08-16
DE69332904D1 (de) 2003-05-28
WO1994006454A3 (en) 1994-08-18
PL307864A1 (en) 1995-06-26
PT666755E (pt) 2003-09-30
FI951078A7 (fi) 1995-03-08
AU681350B2 (en) 1997-08-28
OA10133A (en) 1996-12-18
WO1994006454A2 (en) 1994-03-31
EP0666755B1 (en) 2003-04-23
JP2004002455A (ja) 2004-01-08
UA41338C2 (uk) 2001-09-17
KR100273620B1 (ko) 2000-12-15
FI951078L (fi) 1995-03-08
RU2126266C1 (ru) 1999-02-20
JP3517238B2 (ja) 2004-04-12
KR950703357A (ko) 1995-09-20

Similar Documents

Publication Publication Date Title
RU95106823A (ru) Сукциноиламиногидроксиэтиламиносульфонамиды, фармацевтическая композиция, способ ингибирования ретровирусной протеазы, способ лечения ретровирусной инфекции способ лечения спида
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
MX9706913A (es) Compuestos de bis-aminacido-hidroxietilamina-sulfonamida inhibidoresde proteasan retroviral, composiciones que los contienen y ek uso de los mismos.
ATE193304T1 (de) Inhibitoren der menschlichen neutrophilenelastase
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
AU8125694A (en) 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
NO983688L (no) Serin-protease-inhibitorer
EP0677048A1 (en) CYCLIC SULPHONES AS INHIBITORS RETROVIRAL PROTEASES.
BG100016A (bg) Нiv протеазни инхибитори във фармацевтични комбинации за лечение на спин
NO974147D0 (no) Heterocykelkarbonyl aminosyre hydroksyetylamino sulfonamid retroviral protease
NO983991L (no) Serin-protease-inhibitorer
FI962021A0 (fi) 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
NO950897D0 (no) Inhibisjon av retro virusinfeksjon
IT1300056B1 (it) Eterocicli con anello a 6 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmaci
MX9304351A (es) Inhibidores de proteasas de aminodiol y composiciones farmaceuticas que los incluyen.